Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity

NCT06757725 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT06757725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06757725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 3, 2022
Completion date
October 15, 2023
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus flare, lupus glomerulonephritis, systemic lupus erthematosus